Cargando…

Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes

AIMS: Changes in the islet vasculature have been implicated in the regulation of β-cell survival and function during the progression to type 2 diabetes (T2D). Failure of the β-cell to compensate for the increased insulin demand in obesity eventually leads to diabetes; as a result of the complex inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Payal, Lueschen, Navina, Ardestani, Amin, Oberholzer, Jose, Olerud, Johan, Carlsson, Per-Ola, Maedler, Kathrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019443/
https://www.ncbi.nlm.nih.gov/pubmed/27617438
http://dx.doi.org/10.1371/journal.pone.0161834
_version_ 1782453059255795712
author Shah, Payal
Lueschen, Navina
Ardestani, Amin
Oberholzer, Jose
Olerud, Johan
Carlsson, Per-Ola
Maedler, Kathrin
author_facet Shah, Payal
Lueschen, Navina
Ardestani, Amin
Oberholzer, Jose
Olerud, Johan
Carlsson, Per-Ola
Maedler, Kathrin
author_sort Shah, Payal
collection PubMed
description AIMS: Changes in the islet vasculature have been implicated in the regulation of β-cell survival and function during the progression to type 2 diabetes (T2D). Failure of the β-cell to compensate for the increased insulin demand in obesity eventually leads to diabetes; as a result of the complex interplay of genetic and environmental factors (e.g. ongoing inflammation within the islets) and impaired vascular function. The Angiopoietin/Tie (Ang/Tie) angiogenic system maintains vasculature and is closely related to organ inflammation and angiogenesis. In this study we aimed to identify whether the vessel area within the islets changes in diabetes and whether such changes would be triggered by the Tie-antagonist Ang-2. METHODS: Immunohistochemical and qPCR analyses to follow islet vascularization and Ang/Tie levels were performed in human pancreatic autopsies and isolated human and mouse islets. The effect of Ang-2 was assessed in β-cell-specific Ang-2 overexpressing mice during high fat diet (HFD) feeding. RESULTS: Islet vessel area was increased in autopsy pancreases from patients with T2D. The vessel markers Tie-1, Tie-2 and CD31 were upregulated in mouse islets upon HFD feeding from 8 to 24 weeks. Ang-2 was transiently upregulated in mouse islets at 8 weeks of HFD and under glucolipotoxic conditions (22.2 mM glucose/ 0.5 mM palmitate) in vitro in human and mouse islets, in contrast to its downregulation by cytokines (IL-1β, IFN-ɣ and TNF-α). Ang-1 on the other hand was oppositely regulated, with a significant loss under glucolipotoxic condition, a trend to reduce in islets from patients with T2D and an upregulation by cytokines. Modulation of such changes in Ang-2 by its overexpression or the inhibition of its receptor Tie-2 impaired β-cell function at basal conditions but protected islets from cytokine induced apoptosis. In vivo, β-cell-specific Ang-2 overexpression in mice induced hypervascularization under normal diet but contrastingly led to hypovascularized islets in response to HFD together with increased apoptosis and reduced β-cell mass. CONCLUSIONS: Islet hypervascularization occurs in T2D. A balanced expression of the Ang1/Ang2 system is important for islet physiology. Ang-2 prevents β-cell mass and islet vascular adaptation in response to HFD feeding with no major influence on glucose homeostasis.
format Online
Article
Text
id pubmed-5019443
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50194432016-09-27 Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes Shah, Payal Lueschen, Navina Ardestani, Amin Oberholzer, Jose Olerud, Johan Carlsson, Per-Ola Maedler, Kathrin PLoS One Research Article AIMS: Changes in the islet vasculature have been implicated in the regulation of β-cell survival and function during the progression to type 2 diabetes (T2D). Failure of the β-cell to compensate for the increased insulin demand in obesity eventually leads to diabetes; as a result of the complex interplay of genetic and environmental factors (e.g. ongoing inflammation within the islets) and impaired vascular function. The Angiopoietin/Tie (Ang/Tie) angiogenic system maintains vasculature and is closely related to organ inflammation and angiogenesis. In this study we aimed to identify whether the vessel area within the islets changes in diabetes and whether such changes would be triggered by the Tie-antagonist Ang-2. METHODS: Immunohistochemical and qPCR analyses to follow islet vascularization and Ang/Tie levels were performed in human pancreatic autopsies and isolated human and mouse islets. The effect of Ang-2 was assessed in β-cell-specific Ang-2 overexpressing mice during high fat diet (HFD) feeding. RESULTS: Islet vessel area was increased in autopsy pancreases from patients with T2D. The vessel markers Tie-1, Tie-2 and CD31 were upregulated in mouse islets upon HFD feeding from 8 to 24 weeks. Ang-2 was transiently upregulated in mouse islets at 8 weeks of HFD and under glucolipotoxic conditions (22.2 mM glucose/ 0.5 mM palmitate) in vitro in human and mouse islets, in contrast to its downregulation by cytokines (IL-1β, IFN-ɣ and TNF-α). Ang-1 on the other hand was oppositely regulated, with a significant loss under glucolipotoxic condition, a trend to reduce in islets from patients with T2D and an upregulation by cytokines. Modulation of such changes in Ang-2 by its overexpression or the inhibition of its receptor Tie-2 impaired β-cell function at basal conditions but protected islets from cytokine induced apoptosis. In vivo, β-cell-specific Ang-2 overexpression in mice induced hypervascularization under normal diet but contrastingly led to hypovascularized islets in response to HFD together with increased apoptosis and reduced β-cell mass. CONCLUSIONS: Islet hypervascularization occurs in T2D. A balanced expression of the Ang1/Ang2 system is important for islet physiology. Ang-2 prevents β-cell mass and islet vascular adaptation in response to HFD feeding with no major influence on glucose homeostasis. Public Library of Science 2016-09-12 /pmc/articles/PMC5019443/ /pubmed/27617438 http://dx.doi.org/10.1371/journal.pone.0161834 Text en © 2016 Shah et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Shah, Payal
Lueschen, Navina
Ardestani, Amin
Oberholzer, Jose
Olerud, Johan
Carlsson, Per-Ola
Maedler, Kathrin
Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes
title Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes
title_full Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes
title_fullStr Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes
title_full_unstemmed Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes
title_short Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes
title_sort angiopoetin-2 signals do not mediate the hypervascularization of islets in type 2 diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019443/
https://www.ncbi.nlm.nih.gov/pubmed/27617438
http://dx.doi.org/10.1371/journal.pone.0161834
work_keys_str_mv AT shahpayal angiopoetin2signalsdonotmediatethehypervascularizationofisletsintype2diabetes
AT lueschennavina angiopoetin2signalsdonotmediatethehypervascularizationofisletsintype2diabetes
AT ardestaniamin angiopoetin2signalsdonotmediatethehypervascularizationofisletsintype2diabetes
AT oberholzerjose angiopoetin2signalsdonotmediatethehypervascularizationofisletsintype2diabetes
AT olerudjohan angiopoetin2signalsdonotmediatethehypervascularizationofisletsintype2diabetes
AT carlssonperola angiopoetin2signalsdonotmediatethehypervascularizationofisletsintype2diabetes
AT maedlerkathrin angiopoetin2signalsdonotmediatethehypervascularizationofisletsintype2diabetes